SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-000153
Filing Date
2018-01-05
Accepted
2018-01-05 17:29:26
Documents
4
Period of Report
2018-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mdit8k_jan22018.htm 8-K 26522
2 RESIGNATION LETTER OF SUSAN WEISMAN ex99-1.htm EX-99.1 1750
3 RESIGNATION LETTER OF ERIC GOEHAUSEN ex99-2.htm EX-99.2 4409
4 IMAGE resignation000.jpg GRAPHIC 64855
  Complete submission text file 0001654954-18-000153.txt   123682
Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610
Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290
Medite Cancer Diagnostics, Inc. (Filer) CIK: 0000075439 (see all company filings)

IRS No.: 364296006 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-00935 | Film No.: 18514322
SIC: 3841 Surgical & Medical Instruments & Apparatus